Diane V. Havlir

Active 1991–2025

192
Papers
42,083
Citations
91
h-index
187
i10-index

Citations

Citations per year for Diane V. Havlir1982: 1 citations1990: 1 citations1991: 3 citations1992: 22 citations1993: 29 citations1994: 23 citations1995: 43 citations1996: 52 citations1997: 59 citations1998: 233 citations1999: 252 citations2000: 257 citations2001: 257 citations2002: 256 citations2003: 235 citations2004: 243 citations2005: 227 citations2006: 198 citations2007: 154 citations2008: 192 citations2009: 229 citations2010: 190 citations2011: 234 citations2012: 314 citations2013: 308 citations2014: 312 citations2015: 281 citations2016: 284 citations2017: 215 citations2018: 228 citations2019: 1,085 citations2020: 1,256 citations2021: 1,094 citations2022: 730 citations2023: 437 citations2024: 776 citations2025: 318 citations2026: 9 citations1983–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,373 citing papers, 32.1% of this breakdownUnited Kingdom: 1,368 citing papers, 8.2% of this breakdownSouth Africa: 775 citing papers, 4.6% of this breakdownCanada: 649 citing papers, 3.9% of this breakdownFrance: 581 citing papers, 3.5% of this breakdownSwitzerland: 524 citing papers, 3.1% of this breakdownAustralia: 478 citing papers, 2.9% of this breakdownGermany: 455 citing papers, 2.7% of this breakdownUganda: 441 citing papers, 2.6% of this breakdownNetherlands: 427 citing papers, 2.5% of this breakdownItaly: 379 citing papers, 2.3% of this breakdownSpain: 354 citing papers, 2.1% of this breakdown
0%32.1%Other 29.5%

Fields

  • Medicine61.6%
  • Immunology and Microbiology28.3%
  • Biochemistry, Genetics and Molecular Biology2.6%
  • Health Professions1.7%
  • Mathematics1.7%
  • Social Sciences1%
  • Other3.1%

Topics

  • HIV/AIDS Research and Interventions14%
  • HIV Research and Treatment13.3%
  • HIV/AIDS drug development and treatment8.7%
  • HIV-related health complications and treatments4.5%
  • Immune Cell Function and Interaction4.2%
  • HIV, Drug Use, Sexual Risk3.5%
  • Other51.8%

Coauthors

All papers

Open in search
  1. Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 439

  2. The end of AIDS: HIV infection as a chronic disease

    Authors: , , - The Lancet 2013 cited by 2,067

  3. Prevention of HIV-1 Infection with Early Antiretroviral Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Taha E. Taha, Karin Nielsen‐Saines, David D. Celentano, Max Essex, Thomas R. Fleming - New England Journal of Medicine 2011 cited by 6,962

  4. Antiretroviral Therapy for the Prevention of HIV-1 Transmission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karin Nielsen‐Saines, David D. Celentano, Max Essex, Sarah E. Hudelson, Andrew D. Redd, Thomas R. Fleming - New England Journal of Medicine 2016 cited by 1,726

  5. Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

    Authors: , , , , , , - Science 1997 cited by 2,235

  6. First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic

    Authors: , , , , , , , , , , - Clinical Infectious Diseases 2022 cited by 134

  7. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Piot, Anton Pozniak, Thomas C. Quinn, Jürgen K. Rockstroh, Jirair Ratevosian, Owen Ryan, Serra Sippel, Bruno Spire, Agnès Soucat, Ann Starrs, Steffanie A. Strathdee, Nicholas M. Thomson, Stefano Vella, Mauro Schechter, Peter Vickerman, Brian W. Weir, Chris Beyrer - The Lancet 2018 cited by 761

  8. Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexis J. Combes, Arjun A. Rao, Yun S. Song, Gabriela K. Fragiadakis, Kirsten N. Kangelaris, Carolyn S. Calfee, David J. Erle, Carolyn M. Hendrickson, Matthew F. Krummel, Prescott G. Woodruff, Charles Langelier, Jean‐Laurent Casanova, Joseph L. DeRisi, Mark S. Anderson, Chun Ye - Science Translational Medicine 2021 cited by 238

  9. Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV

    Authors: , , , , , , , , , , , , , , - Annals of Internal Medicine 2023 cited by 108

  10. Machine Learning to Identify Persons at High-Risk of Human Immunodeficiency Virus Acquisition in Rural Kenya and Uganda

    Authors: , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2019 cited by 80

  11. HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2000 cited by 864

  12. HIV post-treatment controllers have distinct immunological and virological features

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 65

  13. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2002 cited by 1,566

  14. Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 238

  15. HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Harsha Thirumurthy, Catherine A. Koss, Lillian B. Brown, Carina Marquez, Joshua Schwab, Geoff Lavoy, Albert Plenty, Erick Wafula, Patrick Omanya, Yea‐Hung Chen, James F. Rooney, Melanie C. Bacon, Mark van der Laan, Craig R. Cohen, Elizabeth A. Bukusi, Moses R. Kamya, Maya L. Petersen - New England Journal of Medicine 2019 cited by 226

  16. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - AIDS and Behavior 2020 cited by 114

  17. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation

    Authors: , , , , , , , - Nature Medicine 2016 cited by 102

  18. Monthly sulfadoxine–pyrimethamine versus dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial

    Authors: , , , , , , , , , , , , , - The Lancet 2019 cited by 127

  19. Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2018 cited by 127

  20. Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia

    Authors: , , , , , , , , , , , , - Clinical Infectious Diseases 2024 cited by 44

  21. Sudden Cardiac Death in Patients With Human Immunodeficiency Virus Infection

    Authors: , , , , , , , - Journal of the American College of Cardiology 2012 cited by 271

  22. Men “missing” from population-based HIV testing: insights from qualitative research

    Authors: , , , , , , , , , , , , , , - AIDS Care 2016 cited by 191

  23. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Max Essex, Diane V. Havlir, Myron S. Cohen - The Lancet Infectious Diseases 2014 cited by 511

  24. Differences in HIV Burden and Immune Activation within the Gut of HIV‐Positive Patients Receiving Suppressive Antiretroviral Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2010 cited by 292